Cargando…
A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer
The human genome contains regulatory elements, such as enhancers, that are often rewired by cancer cells for the activation of genes that promote tumorigenesis and resistance to therapy. This is especially true for cancers that have little or no known driver mutations within protein coding genes, su...
Autores principales: | Kelly, Michael R., Wisniewska, Kamila, Regner, Matthew J., Lewis, Michael W., Perreault, Andrea A., Davis, Eric S., Phanstiel, Douglas H., Parker, Joel S., Franco, Hector L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307778/ https://www.ncbi.nlm.nih.gov/pubmed/35869079 http://dx.doi.org/10.1038/s41467-022-31919-8 |
Ejemplares similares
-
Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer
por: Lewis, Michael W., et al.
Publicado: (2022) -
Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
por: Kim, Hyunsoo, et al.
Publicado: (2023) -
Multi-omic Dissection of Oncogenically Active Epiproteomes Identifies Drivers of Proliferative and Invasive Breast Tumors
por: Wrobel, John A., et al.
Publicado: (2019) -
Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma
por: Li, Lin, et al.
Publicado: (2021) -
Guiding the design of well-powered Hi-C experiments to detect differential loops
por: Parker, Sarah M, et al.
Publicado: (2023)